Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Annals of Internal Medicine
|
October 22, 2008
Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact
Mustafa Bakir, Kerry A Millington, Ahmet Soysal, et al.
Plos One
|
January 5, 2012
Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression
Davinder P S Dosanjh, Mustafa Bakir, Kerry A Millington, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 4, 2007
Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load
Kerry A Millington, John A Innes, Sarah Hackforth, et al.
Annals of Internal Medicine
|
March 5, 2008
Improved diagnostic evaluation of suspected tuberculosis
Davinder P S Dosanjh, Timothy S C Hinks, John A Innes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 7, 2009
Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts
Mustafa Bakir, Davinder P S Dosanjh, Jonathan J Deeks, et al.
BMJ Open Respiratory Research
|
July 7, 2021
Increase in recruitment upon integration of trial into a clinical care pathway: an observational study
Kay Por Yip, Simon Gompertz, Catherine Snelson, et al.
Infection and Immunity
|
September 16, 2009
Frequencies of region of difference 1 antigen-specific but not purified protein derivative-specific gamma interferon-secreting T cells correlate with the presence of tuberculosis disease but do not distinguish recent from remote latent infections
Timothy S C Hinks, Davinder P S Dosanjh, John A Innes, et al.
The Journal of Allergy and Clinical Immunology
|
January 14, 2026
First-in-human study for londamocitinib (AZD4604), an inhaled, selective JAK1 inhibitor
Tina Jellesmark Jensen, Camille Riff, Julia Lund, et al.
ERJ Open Research
|
March 30, 2023
Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study
Phillip D Monk, Jody L Brookes, Victoria J Tear, et al.
The Journal of Allergy and Clinical Immunology
|
April 22, 2026
AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trial
Sarah R Doffman, Davinder P S Dosanjh, Muhammad Waqas Sadiq, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Annals of Internal Medicine
|
October 22, 2008
Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact
Mustafa Bakir, Kerry A Millington, Ahmet Soysal, et al.
Plos One
|
January 5, 2012
Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression
Davinder P S Dosanjh, Mustafa Bakir, Kerry A Millington, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 4, 2007
Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load
Kerry A Millington, John A Innes, Sarah Hackforth, et al.
Annals of Internal Medicine
|
March 5, 2008
Improved diagnostic evaluation of suspected tuberculosis
Davinder P S Dosanjh, Timothy S C Hinks, John A Innes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 7, 2009
Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts
Mustafa Bakir, Davinder P S Dosanjh, Jonathan J Deeks, et al.
BMJ Open Respiratory Research
|
July 7, 2021
Increase in recruitment upon integration of trial into a clinical care pathway: an observational study
Kay Por Yip, Simon Gompertz, Catherine Snelson, et al.
Infection and Immunity
|
September 16, 2009
Frequencies of region of difference 1 antigen-specific but not purified protein derivative-specific gamma interferon-secreting T cells correlate with the presence of tuberculosis disease but do not distinguish recent from remote latent infections
Timothy S C Hinks, Davinder P S Dosanjh, John A Innes, et al.
The Journal of Allergy and Clinical Immunology
|
January 14, 2026
First-in-human study for londamocitinib (AZD4604), an inhaled, selective JAK1 inhibitor
Tina Jellesmark Jensen, Camille Riff, Julia Lund, et al.
ERJ Open Research
|
March 30, 2023
Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study
Phillip D Monk, Jody L Brookes, Victoria J Tear, et al.
The Journal of Allergy and Clinical Immunology
|
April 22, 2026
AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trial
Sarah R Doffman, Davinder P S Dosanjh, Muhammad Waqas Sadiq, et al.
Page
of 2